ESLAW (STOCKS)
Estrella Immunopharma, Inc. Warrant
—
Change: —
Prev close: —
Company Information
- Exchange
- XNAS
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $13.06M |
| Research and Development | $10.25M |
| Other Operating Expenses | $2.81M |
| Operating Income/Loss | -$13.06M |
| Income/Loss From Continuing Operations After Tax | -$13.06M |
| Income/Loss From Continuing Operations Before Tax | -$13.06M |
| Income Tax Expense/Benefit | $838.00 |
| Net Income/Loss | -$13.06M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$13.06M |
| Net Income/Loss Available To Common Stockholders, Basic | -$13.06M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.35 |
| Diluted Earnings Per Share | -$0.35 |
| Basic Average Shares | 36,820,810 |
| Diluted Average Shares | 36,820,810 |
| Assets | $3.18M |
| Current Assets | $1.68M |
| Noncurrent Assets | $1.50M |
| Liabilities | $13.54M |
| Current Liabilities | $13.54M |
| Noncurrent Liabilities | $0.00 |
| Equity | -$10.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$10.37M |
| Liabilities And Equity | $3.18M |
| Net Cash Flow From Operating Activities | -$1.79M |
| Net Cash Flow From Operating Activities, Continuing | -$1.79M |
| Net Cash Flow From Investing Activities | -$467.39K |
| Net Cash Flow From Investing Activities, Continuing | -$467.39K |
| Net Cash Flow From Financing Activities | $2.25M |
| Net Cash Flow From Financing Activities, Continuing | $2.25M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$13.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.06M |
| Other Comprehensive Income/Loss | $0.00 |